Skip to main content
SpringerLink
Log in

Blood Transfusion in Cytoreductive Surgery: Better Not at All

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Acheson AG, Brookes MJ, Spahn DR. Effects of allogeneic red blood cell transfusions on clinical outcomes in patients undergoing colorectal cancer surgery: a systematic review and meta-analysis. Ann Surg. 2012;256:235–44.

    Article  PubMed  Google Scholar 

  2. Amato A, Pescatori M. Perioperative blood transfusions for the recurrence of colorectal cancer. Cochrane Database Syst Rev. 2006(1):CD005033.

  3. Saxena A, Valle SJ, Liauw W, Morris DL. Allogenic blood transfusion is an independent predictor of poorer perioperative outcomes and reduced long-term survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a review of 936 cases. J Gastrointest Surg. 2017;21:1318–27.

    Article  PubMed  Google Scholar 

  4. Saxena A, Yan TD, Chua TC, et al. Risk factors for massive blood transfusion in cytoreductive surgery: a multivariate analysis of 243 procedures. Ann Surg Oncol. 2009;16:2195–203.

    Article  PubMed  Google Scholar 

  5. Nizri E, Kusamura S, Fallabrino G, Guaglio M, Baratti D, Deraco M. Dose-dependent effect of red blood cells transfusion on perioperative and long-term outcomes in peritoneal surface malignancies treated with cytoreduction and HIPEC. Ann Surg Oncol. 2018;25:3264–70.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Surgery, Department of Surgery A, Tel-Aviv Sourasky Medical Center and Sackler Faculty of Medicine, TelAviv University, Tel-Aviv, Israel

    Eran Nizri MD, PhD

  2. Peritoneal Surface Malignancies Unit, Colon and Rectal Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

    Eran Nizri MD, PhD, Shigeki Kusamura MD, PhD & Marcello Deraco MD

Authors
  1. Eran Nizri MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shigeki Kusamura MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marcello Deraco MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eran Nizri MD, PhD.

Ethics declarations

Disclosure

There are no conflicts of interest.

Additional information

ASO Author Reflections offer a brief invited commentary on the article, Dose-Dependent Effect of Red Blood Cells Transfusion on Perioperative and Long-Term Outcomes in Peritoneal Surface Malignancies Treated With Cytoreduction and HIPEC. Ann Surg Oncol. 2018;25:3264–70.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nizri, E., Kusamura, S. & Deraco, M. Blood Transfusion in Cytoreductive Surgery: Better Not at All. Ann Surg Oncol 25 (Suppl 3), 711–712 (2018). https://doi.org/10.1245/s10434-018-6814-x

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-018-6814-x

Keywords

Search

Navigation